Pharma & Healthcare
Global Antiulcerant Drugs Market Research Report 2024
- Jan 29, 24
- ID: 49810
- Pages: 77
- Figures: 143
- Views: 18
Antiulcerant Drugs are a variety of drugs used to treat gastric and intestinal ulcers.
The global Antiulcerant Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiulcerant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiulcerant Drugs.
Report Scope
The Antiulcerant Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiulcerant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiulcerant Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire
Segment by Type
Proton Pump Inhibitors
H2 Receptor Antagonists
Gastric Mucosal Protective Drugs
Antibiotics
Antacids
Prostaglandin Agonists
Segment by Application
Mouth Ulcers
Stomach Ulcers
Leg Ulcer
Esophageal Ulcer
Bleeding Ulcer
Neuropathic Ulcers
Venous Stasis Ulcers
Arterial (Ischemic) Ulcers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiulcerant Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Antiulcerant Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiulcerant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiulcerant Drugs.
Report Scope
The Antiulcerant Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiulcerant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiulcerant Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire
Segment by Type
Proton Pump Inhibitors
H2 Receptor Antagonists
Gastric Mucosal Protective Drugs
Antibiotics
Antacids
Prostaglandin Agonists
Segment by Application
Mouth Ulcers
Stomach Ulcers
Leg Ulcer
Esophageal Ulcer
Bleeding Ulcer
Neuropathic Ulcers
Venous Stasis Ulcers
Arterial (Ischemic) Ulcers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiulcerant Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiulcerant Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proton Pump Inhibitors
1.2.3 H2 Receptor Antagonists
1.2.4 Gastric Mucosal Protective Drugs
1.2.5 Antibiotics
1.2.6 Antacids
1.2.7 Prostaglandin Agonists
1.3 Market by Application
1.3.1 Global Antiulcerant Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mouth Ulcers
1.3.3 Stomach Ulcers
1.3.4 Leg Ulcer
1.3.5 Esophageal Ulcer
1.3.6 Bleeding Ulcer
1.3.7 Neuropathic Ulcers
1.3.8 Venous Stasis Ulcers
1.3.9 Arterial (Ischemic) Ulcers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiulcerant Drugs Market Perspective (2019-2030)
2.2 Antiulcerant Drugs Growth Trends by Region
2.2.1 Global Antiulcerant Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiulcerant Drugs Historic Market Size by Region (2019-2024)
2.2.3 Antiulcerant Drugs Forecasted Market Size by Region (2025-2030)
2.3 Antiulcerant Drugs Market Dynamics
2.3.1 Antiulcerant Drugs Industry Trends
2.3.2 Antiulcerant Drugs Market Drivers
2.3.3 Antiulcerant Drugs Market Challenges
2.3.4 Antiulcerant Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiulcerant Drugs Players by Revenue
3.1.1 Global Top Antiulcerant Drugs Players by Revenue (2019-2024)
3.1.2 Global Antiulcerant Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Antiulcerant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiulcerant Drugs Revenue
3.4 Global Antiulcerant Drugs Market Concentration Ratio
3.4.1 Global Antiulcerant Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiulcerant Drugs Revenue in 2023
3.5 Antiulcerant Drugs Key Players Head office and Area Served
3.6 Key Players Antiulcerant Drugs Product Solution and Service
3.7 Date of Enter into Antiulcerant Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiulcerant Drugs Breakdown Data by Type
4.1 Global Antiulcerant Drugs Historic Market Size by Type (2019-2024)
4.2 Global Antiulcerant Drugs Forecasted Market Size by Type (2025-2030)
5 Antiulcerant Drugs Breakdown Data by Application
5.1 Global Antiulcerant Drugs Historic Market Size by Application (2019-2024)
5.2 Global Antiulcerant Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiulcerant Drugs Market Size (2019-2030)
6.2 North America Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiulcerant Drugs Market Size by Country (2019-2024)
6.4 North America Antiulcerant Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiulcerant Drugs Market Size (2019-2030)
7.2 Europe Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiulcerant Drugs Market Size by Country (2019-2024)
7.4 Europe Antiulcerant Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiulcerant Drugs Market Size (2019-2030)
8.2 Asia-Pacific Antiulcerant Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiulcerant Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiulcerant Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiulcerant Drugs Market Size (2019-2030)
9.2 Latin America Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiulcerant Drugs Market Size by Country (2019-2024)
9.4 Latin America Antiulcerant Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiulcerant Drugs Market Size (2019-2030)
10.2 Middle East & Africa Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiulcerant Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiulcerant Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Antiulcerant Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Antiulcerant Drugs Introduction
11.2.4 Eisai Revenue in Antiulcerant Drugs Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Daewoong Pharmaceutical
11.3.1 Daewoong Pharmaceutical Company Detail
11.3.2 Daewoong Pharmaceutical Business Overview
11.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Introduction
11.3.4 Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024)
11.3.5 Daewoong Pharmaceutical Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Antiulcerant Drugs Introduction
11.4.4 Allergan Revenue in Antiulcerant Drugs Business (2019-2024)
11.4.5 Allergan Recent Development
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Detail
11.5.2 AstraZeneca plc Business Overview
11.5.3 AstraZeneca plc Antiulcerant Drugs Introduction
11.5.4 AstraZeneca plc Revenue in Antiulcerant Drugs Business (2019-2024)
11.5.5 AstraZeneca plc Recent Development
11.6 Valeant
11.6.1 Valeant Company Detail
11.6.2 Valeant Business Overview
11.6.3 Valeant Antiulcerant Drugs Introduction
11.6.4 Valeant Revenue in Antiulcerant Drugs Business (2019-2024)
11.6.5 Valeant Recent Development
11.7 Zydus
11.7.1 Zydus Company Detail
11.7.2 Zydus Business Overview
11.7.3 Zydus Antiulcerant Drugs Introduction
11.7.4 Zydus Revenue in Antiulcerant Drugs Business (2019-2024)
11.7.5 Zydus Recent Development
11.8 Shire
11.8.1 Shire Company Detail
11.8.2 Shire Business Overview
11.8.3 Shire Antiulcerant Drugs Introduction
11.8.4 Shire Revenue in Antiulcerant Drugs Business (2019-2024)
11.8.5 Shire Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiulcerant Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Proton Pump Inhibitors
1.2.3 H2 Receptor Antagonists
1.2.4 Gastric Mucosal Protective Drugs
1.2.5 Antibiotics
1.2.6 Antacids
1.2.7 Prostaglandin Agonists
1.3 Market by Application
1.3.1 Global Antiulcerant Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mouth Ulcers
1.3.3 Stomach Ulcers
1.3.4 Leg Ulcer
1.3.5 Esophageal Ulcer
1.3.6 Bleeding Ulcer
1.3.7 Neuropathic Ulcers
1.3.8 Venous Stasis Ulcers
1.3.9 Arterial (Ischemic) Ulcers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiulcerant Drugs Market Perspective (2019-2030)
2.2 Antiulcerant Drugs Growth Trends by Region
2.2.1 Global Antiulcerant Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiulcerant Drugs Historic Market Size by Region (2019-2024)
2.2.3 Antiulcerant Drugs Forecasted Market Size by Region (2025-2030)
2.3 Antiulcerant Drugs Market Dynamics
2.3.1 Antiulcerant Drugs Industry Trends
2.3.2 Antiulcerant Drugs Market Drivers
2.3.3 Antiulcerant Drugs Market Challenges
2.3.4 Antiulcerant Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiulcerant Drugs Players by Revenue
3.1.1 Global Top Antiulcerant Drugs Players by Revenue (2019-2024)
3.1.2 Global Antiulcerant Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Antiulcerant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiulcerant Drugs Revenue
3.4 Global Antiulcerant Drugs Market Concentration Ratio
3.4.1 Global Antiulcerant Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiulcerant Drugs Revenue in 2023
3.5 Antiulcerant Drugs Key Players Head office and Area Served
3.6 Key Players Antiulcerant Drugs Product Solution and Service
3.7 Date of Enter into Antiulcerant Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiulcerant Drugs Breakdown Data by Type
4.1 Global Antiulcerant Drugs Historic Market Size by Type (2019-2024)
4.2 Global Antiulcerant Drugs Forecasted Market Size by Type (2025-2030)
5 Antiulcerant Drugs Breakdown Data by Application
5.1 Global Antiulcerant Drugs Historic Market Size by Application (2019-2024)
5.2 Global Antiulcerant Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiulcerant Drugs Market Size (2019-2030)
6.2 North America Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiulcerant Drugs Market Size by Country (2019-2024)
6.4 North America Antiulcerant Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiulcerant Drugs Market Size (2019-2030)
7.2 Europe Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiulcerant Drugs Market Size by Country (2019-2024)
7.4 Europe Antiulcerant Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiulcerant Drugs Market Size (2019-2030)
8.2 Asia-Pacific Antiulcerant Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiulcerant Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiulcerant Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiulcerant Drugs Market Size (2019-2030)
9.2 Latin America Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiulcerant Drugs Market Size by Country (2019-2024)
9.4 Latin America Antiulcerant Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiulcerant Drugs Market Size (2019-2030)
10.2 Middle East & Africa Antiulcerant Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiulcerant Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiulcerant Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Antiulcerant Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Antiulcerant Drugs Introduction
11.2.4 Eisai Revenue in Antiulcerant Drugs Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Daewoong Pharmaceutical
11.3.1 Daewoong Pharmaceutical Company Detail
11.3.2 Daewoong Pharmaceutical Business Overview
11.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Introduction
11.3.4 Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024)
11.3.5 Daewoong Pharmaceutical Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Antiulcerant Drugs Introduction
11.4.4 Allergan Revenue in Antiulcerant Drugs Business (2019-2024)
11.4.5 Allergan Recent Development
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Detail
11.5.2 AstraZeneca plc Business Overview
11.5.3 AstraZeneca plc Antiulcerant Drugs Introduction
11.5.4 AstraZeneca plc Revenue in Antiulcerant Drugs Business (2019-2024)
11.5.5 AstraZeneca plc Recent Development
11.6 Valeant
11.6.1 Valeant Company Detail
11.6.2 Valeant Business Overview
11.6.3 Valeant Antiulcerant Drugs Introduction
11.6.4 Valeant Revenue in Antiulcerant Drugs Business (2019-2024)
11.6.5 Valeant Recent Development
11.7 Zydus
11.7.1 Zydus Company Detail
11.7.2 Zydus Business Overview
11.7.3 Zydus Antiulcerant Drugs Introduction
11.7.4 Zydus Revenue in Antiulcerant Drugs Business (2019-2024)
11.7.5 Zydus Recent Development
11.8 Shire
11.8.1 Shire Company Detail
11.8.2 Shire Business Overview
11.8.3 Shire Antiulcerant Drugs Introduction
11.8.4 Shire Revenue in Antiulcerant Drugs Business (2019-2024)
11.8.5 Shire Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antiulcerant Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Proton Pump Inhibitors
Table 3. Key Players of H2 Receptor Antagonists
Table 4. Key Players of Gastric Mucosal Protective Drugs
Table 5. Key Players of Antibiotics
Table 6. Key Players of Antacids
Table 7. Key Players of Prostaglandin Agonists
Table 8. Global Antiulcerant Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Antiulcerant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Antiulcerant Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Antiulcerant Drugs Market Share by Region (2019-2024)
Table 12. Global Antiulcerant Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Antiulcerant Drugs Market Share by Region (2025-2030)
Table 14. Antiulcerant Drugs Market Trends
Table 15. Antiulcerant Drugs Market Drivers
Table 16. Antiulcerant Drugs Market Challenges
Table 17. Antiulcerant Drugs Market Restraints
Table 18. Global Antiulcerant Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Antiulcerant Drugs Market Share by Players (2019-2024)
Table 20. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiulcerant Drugs as of 2023)
Table 21. Ranking of Global Top Antiulcerant Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Antiulcerant Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiulcerant Drugs Product Solution and Service
Table 25. Date of Enter into Antiulcerant Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiulcerant Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Antiulcerant Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Antiulcerant Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Antiulcerant Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Antiulcerant Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Antiulcerant Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Antiulcerant Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Antiulcerant Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Antiulcerant Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Antiulcerant Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Antiulcerant Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Takeda Pharmaceutical Company Detail
Table 51. Takeda Pharmaceutical Business Overview
Table 52. Takeda Pharmaceutical Antiulcerant Drugs Product
Table 53. Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 54. Takeda Pharmaceutical Recent Development
Table 55. Eisai Company Detail
Table 56. Eisai Business Overview
Table 57. Eisai Antiulcerant Drugs Product
Table 58. Eisai Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 59. Eisai Recent Development
Table 60. Daewoong Pharmaceutical Company Detail
Table 61. Daewoong Pharmaceutical Business Overview
Table 62. Daewoong Pharmaceutical Antiulcerant Drugs Product
Table 63. Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 64. Daewoong Pharmaceutical Recent Development
Table 65. Allergan Company Detail
Table 66. Allergan Business Overview
Table 67. Allergan Antiulcerant Drugs Product
Table 68. Allergan Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 69. Allergan Recent Development
Table 70. AstraZeneca plc Company Detail
Table 71. AstraZeneca plc Business Overview
Table 72. AstraZeneca plc Antiulcerant Drugs Product
Table 73. AstraZeneca plc Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 74. AstraZeneca plc Recent Development
Table 75. Valeant Company Detail
Table 76. Valeant Business Overview
Table 77. Valeant Antiulcerant Drugs Product
Table 78. Valeant Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 79. Valeant Recent Development
Table 80. Zydus Company Detail
Table 81. Zydus Business Overview
Table 82. Zydus Antiulcerant Drugs Product
Table 83. Zydus Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 84. Zydus Recent Development
Table 85. Shire Company Detail
Table 86. Shire Business Overview
Table 87. Shire Antiulcerant Drugs Product
Table 88. Shire Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 89. Shire Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiulcerant Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiulcerant Drugs Market Share by Type: 2023 VS 2030
Figure 3. Proton Pump Inhibitors Features
Figure 4. H2 Receptor Antagonists Features
Figure 5. Gastric Mucosal Protective Drugs Features
Figure 6. Antibiotics Features
Figure 7. Antacids Features
Figure 8. Prostaglandin Agonists Features
Figure 9. Global Antiulcerant Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Antiulcerant Drugs Market Share by Application: 2023 VS 2030
Figure 11. Mouth Ulcers Case Studies
Figure 12. Stomach Ulcers Case Studies
Figure 13. Leg Ulcer Case Studies
Figure 14. Esophageal Ulcer Case Studies
Figure 15. Bleeding Ulcer Case Studies
Figure 16. Neuropathic Ulcers Case Studies
Figure 17. Venous Stasis Ulcers Case Studies
Figure 18. Arterial (Ischemic) Ulcers Case Studies
Figure 19. Others Case Studies
Figure 20. Antiulcerant Drugs Report Years Considered
Figure 21. Global Antiulcerant Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 22. Global Antiulcerant Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 23. Global Antiulcerant Drugs Market Share by Region: 2023 VS 2030
Figure 24. Global Antiulcerant Drugs Market Share by Players in 2023
Figure 25. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiulcerant Drugs as of 2023)
Figure 26. The Top 10 and 5 Players Market Share by Antiulcerant Drugs Revenue in 2023
Figure 27. North America Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. North America Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 29. United States Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Canada Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 33. Germany Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia-Pacific Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Asia-Pacific Antiulcerant Drugs Market Share by Region (2019-2030)
Figure 41. China Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Japan Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Latin America Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Latin America Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 49. Mexico Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Brazil Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 53. Turkey Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 56. Eisai Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 57. Daewoong Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 58. Allergan Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 59. AstraZeneca plc Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 60. Valeant Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 61. Zydus Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 62. Shire Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Antiulcerant Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Proton Pump Inhibitors
Table 3. Key Players of H2 Receptor Antagonists
Table 4. Key Players of Gastric Mucosal Protective Drugs
Table 5. Key Players of Antibiotics
Table 6. Key Players of Antacids
Table 7. Key Players of Prostaglandin Agonists
Table 8. Global Antiulcerant Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Antiulcerant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Antiulcerant Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Antiulcerant Drugs Market Share by Region (2019-2024)
Table 12. Global Antiulcerant Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Antiulcerant Drugs Market Share by Region (2025-2030)
Table 14. Antiulcerant Drugs Market Trends
Table 15. Antiulcerant Drugs Market Drivers
Table 16. Antiulcerant Drugs Market Challenges
Table 17. Antiulcerant Drugs Market Restraints
Table 18. Global Antiulcerant Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Antiulcerant Drugs Market Share by Players (2019-2024)
Table 20. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiulcerant Drugs as of 2023)
Table 21. Ranking of Global Top Antiulcerant Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Antiulcerant Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiulcerant Drugs Product Solution and Service
Table 25. Date of Enter into Antiulcerant Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiulcerant Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Antiulcerant Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Antiulcerant Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Antiulcerant Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Antiulcerant Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Antiulcerant Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Antiulcerant Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Antiulcerant Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Antiulcerant Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Antiulcerant Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Antiulcerant Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Antiulcerant Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antiulcerant Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Takeda Pharmaceutical Company Detail
Table 51. Takeda Pharmaceutical Business Overview
Table 52. Takeda Pharmaceutical Antiulcerant Drugs Product
Table 53. Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 54. Takeda Pharmaceutical Recent Development
Table 55. Eisai Company Detail
Table 56. Eisai Business Overview
Table 57. Eisai Antiulcerant Drugs Product
Table 58. Eisai Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 59. Eisai Recent Development
Table 60. Daewoong Pharmaceutical Company Detail
Table 61. Daewoong Pharmaceutical Business Overview
Table 62. Daewoong Pharmaceutical Antiulcerant Drugs Product
Table 63. Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 64. Daewoong Pharmaceutical Recent Development
Table 65. Allergan Company Detail
Table 66. Allergan Business Overview
Table 67. Allergan Antiulcerant Drugs Product
Table 68. Allergan Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 69. Allergan Recent Development
Table 70. AstraZeneca plc Company Detail
Table 71. AstraZeneca plc Business Overview
Table 72. AstraZeneca plc Antiulcerant Drugs Product
Table 73. AstraZeneca plc Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 74. AstraZeneca plc Recent Development
Table 75. Valeant Company Detail
Table 76. Valeant Business Overview
Table 77. Valeant Antiulcerant Drugs Product
Table 78. Valeant Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 79. Valeant Recent Development
Table 80. Zydus Company Detail
Table 81. Zydus Business Overview
Table 82. Zydus Antiulcerant Drugs Product
Table 83. Zydus Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 84. Zydus Recent Development
Table 85. Shire Company Detail
Table 86. Shire Business Overview
Table 87. Shire Antiulcerant Drugs Product
Table 88. Shire Revenue in Antiulcerant Drugs Business (2019-2024) & (US$ Million)
Table 89. Shire Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiulcerant Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiulcerant Drugs Market Share by Type: 2023 VS 2030
Figure 3. Proton Pump Inhibitors Features
Figure 4. H2 Receptor Antagonists Features
Figure 5. Gastric Mucosal Protective Drugs Features
Figure 6. Antibiotics Features
Figure 7. Antacids Features
Figure 8. Prostaglandin Agonists Features
Figure 9. Global Antiulcerant Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Antiulcerant Drugs Market Share by Application: 2023 VS 2030
Figure 11. Mouth Ulcers Case Studies
Figure 12. Stomach Ulcers Case Studies
Figure 13. Leg Ulcer Case Studies
Figure 14. Esophageal Ulcer Case Studies
Figure 15. Bleeding Ulcer Case Studies
Figure 16. Neuropathic Ulcers Case Studies
Figure 17. Venous Stasis Ulcers Case Studies
Figure 18. Arterial (Ischemic) Ulcers Case Studies
Figure 19. Others Case Studies
Figure 20. Antiulcerant Drugs Report Years Considered
Figure 21. Global Antiulcerant Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 22. Global Antiulcerant Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 23. Global Antiulcerant Drugs Market Share by Region: 2023 VS 2030
Figure 24. Global Antiulcerant Drugs Market Share by Players in 2023
Figure 25. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiulcerant Drugs as of 2023)
Figure 26. The Top 10 and 5 Players Market Share by Antiulcerant Drugs Revenue in 2023
Figure 27. North America Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. North America Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 29. United States Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Canada Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 33. Germany Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia-Pacific Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Asia-Pacific Antiulcerant Drugs Market Share by Region (2019-2030)
Figure 41. China Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Japan Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Latin America Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Latin America Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 49. Mexico Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Brazil Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Antiulcerant Drugs Market Share by Country (2019-2030)
Figure 53. Turkey Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Antiulcerant Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 56. Eisai Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 57. Daewoong Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 58. Allergan Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 59. AstraZeneca plc Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 60. Valeant Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 61. Zydus Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 62. Shire Revenue Growth Rate in Antiulcerant Drugs Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232